List of contributors
Matthew L. Anderson(Institute for Molecular Medicine), Jason Zhu, R. Ryanne Wu(Palo Alto Institute), Kunle Odunsi(University of Chicago), Matthew Emmet(Massachusetts General Hospital), Rachna T. Shroff(University of Arizona), Sendhilnathan Ramalingam(Duke University), Douglas S. Tyler(University of North Carolina at Chapel Hill), Matthew McKinney, Timothy E. Reddy(Duke University), Aaron D Therien, Michael J. Pishvaian(The University of Texas MD Anderson Cancer Center), David M. Nanus(Cornell University), Jennifer H. Gross(Emory University), Marc Roth(Vanderbilt University), Kathleen Harnden(Inova Fairfax Hospital), Norma E. Farrow(Duke Medical Center), Vanessa C. Stubbs, Georgia M. Beasley(Duke Medical Center), Giovana R. Thomas(National Institutes of Health), Catherine Watson, Kristen K. Ciombor(Vanderbilt University Medical Center), James Isaacs(Duke Medical Center), Ankit Madan(Danville Community College), Angela Pennisi, Rebecca A. Previs(LabCorp (United States)), Tanja Pejović(Oregon Health & Science University), Jeffrey Clarke(Duke Medical Center), Philip Payne(Washington University in St. Louis), Lauren Mauro(Inova Fairfax Hospital), Samuel J. Klempner(Broad Institute), Jonathan R. Brody(Oregon Health & Science University), Ahmed Galal(Montreal Neurological Institute and Hospital), Sandeep S. Davé(Duke University), Daniel Spinosa, Michelle Green(Duke Medical Center), Lori A. Orlando(Duke University), Andrew Berchuck(Duke University), Mary Katherine Montes de, Arnav Mehta(California Institute of Technology), Jingquan Jia(Duke Medical Center), John H. Strickler(Duke Medical Center)
Cited by 0
Related Papers
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
An integrated encyclopedia of DNA elements in the human genome
|The Journal of the American Medical Association (JAMA) Network (American Medical Association)|2012|2.8k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k